norpace cr

Generic: disopyramide phosphate

Labeler: pfizer laboratories div pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name norpace cr
Generic Name disopyramide phosphate
Labeler pfizer laboratories div pfizer inc
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

disopyramide phosphate 150 mg/1

Manufacturer
Pfizer Laboratories Div Pfizer Inc

Identifiers & Regulatory

Product NDC 0025-2742
Product ID 0025-2742_4c146f11-42eb-4767-85e7-edb4b1f0b2cc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018655
Listing Expiration 2026-12-31
Marketing Start 1982-07-20

Pharmacologic Class

Classes
antiarrhythmic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00252742
Hyphenated Format 0025-2742

Supplemental Identifiers

RxCUI
209066 209692 309958 309960 636793 636794 902648 902652
UPC
0300252752314 0300252762313 0300252742315 0300252732316
UNII
N6BOM1935W

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name norpace cr (source: ndc)
Generic Name disopyramide phosphate (source: ndc)
Application Number NDA018655 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2742-31)
source: ndc

Packages (1)

0025-2742-31 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2742-31)

Ingredients (1)

disopyramide phosphate (150 mg/1)

Linked Drug Pages (1)

Norpace CR, Norpace ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4c146f11-42eb-4767-85e7-edb4b1f0b2cc", "openfda": {"upc": ["0300252752314", "0300252762313", "0300252742315", "0300252732316"], "unii": ["N6BOM1935W"], "rxcui": ["209066", "209692", "309958", "309960", "636793", "636794", "902648", "902652"], "spl_set_id": ["e2aa1642-d262-4520-bc6a-9fd3ad795677"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2742-31)", "package_ndc": "0025-2742-31", "marketing_start_date": "19820720"}], "brand_name": "Norpace CR", "product_id": "0025-2742_4c146f11-42eb-4767-85e7-edb4b1f0b2cc", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Antiarrhythmic [EPC]"], "product_ndc": "0025-2742", "generic_name": "disopyramide phosphate", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Norpace CR", "active_ingredients": [{"name": "DISOPYRAMIDE PHOSPHATE", "strength": "150 mg/1"}], "application_number": "NDA018655", "marketing_category": "NDA", "marketing_start_date": "19820720", "listing_expiration_date": "20261231"}